EUROPEAN MARKETS FOR SKIN REPLACEMENTS/SUBSTITUTES AND ACTIVE WOUND REPAIR MODULATORS

207 Pages | 54 Exhibits | 2007 Analysis | Forecasts Through 2012

OVERVIEW:
In 2005, the European skin replacements/ substitutes and active wound repair modulators market totaled approximately $252 million, with skin replacements/substitutes accounting for 21% of sales and active wound repair modulators accounting for the remaining 79% of sales. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 6.6%, reaching approximately $395 million in the year 2012.

This report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European skin replacements/substitutes and active wound repair modulators market. Topics discussed in this report include an overview of the healthcare markets of France, Germany, Italy, Spain, the United Kingdom, the Benelux countries, and the Nordic countries; an overview of clinical issues in wound management; skin replacements/ substitutes such as allografts, autografts, xenografts, and tissue-engineered skin equivalents; and active wound repair modulators such as topical antimicrobials, growth factors, and gene therapy agents.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i.   Methodology

ii.   Major Wound Types

iii.  Skin Replacements/Substitutes

iv.  Active Wound Repair Modulators

v.  Combined Market Forecast

 

Exhibit ES-1:  Major Wound Types, by Cause

Exhibit ES-2:  Europe, Skin Replacements/Substitutes, Market Forecast, by Country, 2002-2012

Exhibit ES-3:  Europe, Topical Antimicrobial Products, Market Forecast, by Country, 2002-2012

Exhibit ES-4:  Skin Replacements/Substitutes and Active Wound Repair Modulators, Combined Market Forecast, 2002-2012

 

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

1.2.6 Benelux

1.2.6.1 Healthcare Organization and Reform

1.2.6.1.1 Belgium

1.2.6.1.2 Luxembourg

1.2.6.1.3 The Netherlands

1.2.6.2 Hospital Services

1.2.6.3 Medical Device Reimbursement

1.2.7 Nordic Countries

1.2.7.1 Healthcare Organization and Reform

1.2.7.1.1 Denmark

1.2.7.1.2 Finland

1.2.7.1.3 Norway

1.2.7.1.4 Sweden

1.2.7.2 Hospital Services

1.2.7.3 Medical Device Reimbursement

 

Exhibit 1-1:    European Union, Medical Devices Risk Classification System

Exhibit 1-2:    European Union, Population Statistics Comparison, 1995 and 2005

Exhibit 1-3:    France, Selected National Healthcare Statistics

Exhibit 1-4:    Germany, Selected National Healthcare Statistics

Exhibit 1-5:    Italy, Selected National Healthcare Statistics

Exhibit 1-6:    Spain, Selected National Healthcare Statistics

Exhibit 1-7:    United Kingdom, Selected National Healthcare Statistics

Exhibit 1-8:    Belgium, Selected National Healthcare Statistics

Exhibit 1-9:    Luxembourg, Selected National Healthcare Statistics

Exhibit 1-10:  The Netherlands, Selected National Healthcare Statistics

Exhibit 1-11:  Denmark, Selected National Healthcare Statistics

Exhibit 1-12:  Finland, Selected National Healthcare Statistics

Exhibit 1-13:  Norway, Selected National Healthcare Statistics

Exhibit 1-14:  Sweden, Selected National Healthcare Statistics

 

2. CLINICAL ISSUES IN WOUND MANAGEMENT

2.1 Physiology of Wound Closure

2.1.1 Layers of the Skin and Supporting Structures

2.1.1.1 Epidermis

2.1.1.2 Dermis

2.1.1.3 Subcutaneous Tissue

2.1.1.4 Fascia

2.1.1.5 Muscle

2.1.1.6 Bone

2.1.2 Wound Closure Process

2.1.2.1 Hemostasis

2.1.2.2 Inflammation

2.1.2.3 Proliferation

2.1.2.4 Remodeling Phase

2.2 Factors Affecting Wound Closure

2.2.1 Extrinsic Factors

2.2.1.1 Desiccation

2.2.1.2 Hydration

2.2.1.3 Infection

2.2.1.4 Maceration

2.2.1.5 Medications and Other Types of Treatment

2.2.1.6 Necrotic Tissue and Debris

2.2.1.7 Oxygenation

2.2.1.8 Stress

2.2.1.9 Temperature

2.2.1.10 Wound Creation and Depth

2.2.1.11 Wound Closure Techniques

2.2.1.12 Other Extrinsic Factors

2.2.2 Intrinsic Factors

2.2.2.1 Body Build

2.2.2.2 Chronic Illness and Age

2.2.2.3 Nutrition

2.2.3 Complications of Wound Healing

2.2.3.1 Bleeding

2.2.3.2 Scarring

2.3 Major Wound Types

2.3.1 Amputation

2.3.2 Arterial Ulcers

2.3.3 Burns

2.3.4 Diabetic Ulcers

2.3.5 Pressure Ulcers

2.3.6 Surgical Wounds

2.3.7 Traumatic Wounds

2.3.8 Venous Ulcers

 

Exhibit 2-1:    Layers of the Skin and Supporting Structures

Exhibit 2-2:    Phases of the Wound Closure Process

Exhibit 2-3:    Intrinsic and Extrinsic Factors Affecting Wound Closure

Exhibit 2-4:    Major Wound Types, by Cause

Exhibit 2-5:    Stages of Burn Wounds

Exhibit 2-6:    Stages of Pressure Ulcers

Exhibit 2-7:    2005, Surgical Procedure Volumes

 

3. SKIN REPLACEMENTS/SUBSTITUTES

3.1 Allografts

3.2 Autografts

3.3 Xenografts

3.4 Amniotic Membranes

3.5 Autologous and Tissue-Engineered Skin Replacements/Substitutes

3.5.1 Epidermal Equivalents

3.5.2 Dermal Equivalents

3.5.3 Composite Bilayer Skin Equivalents

3.6 Market Analysis

3.7 Competitive Analysis

 

Exhibit 3-1:    Advantages and Disadvantages of Allografts

Exhibit 3-2:    2007, Selected Epidermal Equivalent Skin Substitutes

Exhibit 3-3:    2007, Selected Dermal Equivalent Skin Substitutes

Exhibit 3-4:    2007, Selected Composite Bilayer Equivalent Skin Substitutes

Exhibit 3-5:    Europe, Skin Replacements/Substitutes, Market Forecast, by Country, 2002-2012

Exhibit 3-6:    2005, Europe, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-7:    2005, France, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-8:    2005, Germany, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-9:    2005, Italy, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-10:  2005, Spain, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-11:  2005, United Kingdom, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-12:  2005, Benelux Countries, Skin Replacements/Substitutes Market,  Share by Supplier

Exhibit 3-13:  2005, Nordic Countries, Skin Replacements/Substitutes Market, Share by Supplier

Exhibit 3-14:  2005, Rest of Europe, Skin Replacements/Substitutes Market, Share by Supplier

 

4. ACTIVE WOUND REPAIR MODULATORS

4.1 Topical Antimicrobials

4.1.1 Products

4.1.2 Market Analysis

4.1.3 Competitive Analysis

4.2 Growth Factors

4.2.1 Classification of Growth Factors

4.2.1.1 Fibroblast Growth Factor

4.2.1.2 Transforming Growth Factors

4.2.1.3 Epidermal Growth Factors

4.2.1.4 Platelet-Derived Growth Factors

4.2.1.5 Insulin-Like Growth Factors

4.2.1.6 Keratinocyte Growth Factors

4.2.1.7 Vascular Endothelial Growth Factors

4.2.1.8 Autologous Growth Factors

4.2.1.8.1 Biomet Biologics/Biomet

4.2.1.8.2 Cytomedix

4.2.1.8.3 Harvest Technologies

4.2.1.8.4 Medtronic

4.2.1.8.5 PlasmaSeal/Hanuman Medical

4.2.1.9 Angiogenic Growth Factors

4.2.2 Competitors and Products

4.2.3 Market Analysis

4.3 Gene Therapy Agents

4.4 Other Active Wound Repair Modulators

4.4.1 Antibiotics and Anti-Infectives

4.4.2 Hormones

4.4.3 Matrix Metalloproteinase Enzyme Inhibitors

4.4.4 Neuropeptides in Diabetic Wounds

4.4.5 Stem Cells

4.4.6 Other Products

 

Exhibit 4-1:    2007, Selected Topical Antimicrobial Products

Exhibit 4-2:    Europe, Topical Antimicrobial Products, Market Forecast, by Country, 2002-2012

Exhibit 4-3:    2005, Europe, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-4:    2005, France, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-5:    2005, Germany, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-6:    2005, Italy, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-7:    2005, Spain, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-8:    2005, United Kingdom, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-9:    2005, Benelux Countries, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-10:  2005, Nordic Countries, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-11:  2005, Rest of Europe, Topical Antimicrobial Products Market, Share by Supplier

Exhibit 4-12:  2007, Selected Growth Factors Developed for Wound Healing Applications

Exhibit 4-13:  2006, Selected Angiogenic Growth Factors

Exhibit 4-14:  Europe, Growth Factors, Market Forecast, 2002-2012

Exhibit 4-15:  Preclinical Gene Therapy Studies, 1998-2004

 

5. COMPANY PROFILES

5.1     DFB Pharmaceuticals, Inc.

5.2     GlaxoSmithKline PLC

5.3     Integra LifeSciences Holdings Corporation

5.4     Johnson & Johnson Wound Management/Ethicon, Inc./ Johnson & Johnson

5.5     LEO Laboratories LTD

5.6     Mylan Pharmaceuticals, Inc./Mylan Laboratories, Inc

5.7     Ortec International, Inc

5.8     Pfizer, Inc

5.9     Sanofi-aventis

5.10    Smith & Nephew PLC



COMPANIES COVERED:

  1. DFB Pharmaceuticals, Inc.
  2. GlaxoSmithKline PLC
  3. Integra LifeSciences Holdings Corporation
  4. Johnson & Johnson Wound Management/Ethicon, Inc./ Johnson & Johnson
  5. Mylan Pharmaceuticals, Inc./Mylan Laboratories, Inc
  6. Ortec International, Inc
  7. Pfizer, Inc
  8. Sanofi-aventis
  9. Smith & Nephew PLC
Contact Us

Need help finding medtech research? Let us help you!